Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein thiol groups refer to the sulfhydryl (-SH) functional groups present in the side chain of cysteine residues within proteins. These are not a single molecular target or receptor but rather a chemical moiety found in many different proteins. The reactivity and redox state of these groups are central to numerous biological processes: "Thiol functional groups...exhibit distinctive characteristics that confer both chemical reactivity and biological significance...One key role of thiols is their contribution to antioxidant defense mechanisms, where they scavenge reactive oxygen species and protect cells from oxidative damage. Glutathione, a tripeptide containing a thiol group, serves as a primary antioxidant in cells..." In proteins, thiol groups can form disulfide bonds, which stabilize tertiary and quaternary structures; disruption can lead to misfolding or aggregation implicated in diseases such as neurodegeneration. They also participate directly in enzymatic catalysis—especially for enzymes with active-site cysteines—and serve as redox switches regulating protein function. Thiol modifications are reversible under physiological conditions but can become irreversible under excessive oxidative stress or aging, leading to loss of function or increased degradation susceptibility. In laboratory settings and drug development contexts, reducing agents like dithiothreitol (DTT) are used specifically for manipulating these protein features. Because "protein thiol group" refers generically to this functional motif rather than any specific gene product or therapeutic target class such as an enzyme or receptor, it is not considered an individual drug target. Summary judgment: The entry "Protein thiol group" is not a canonical molecular target but describes a widespread chemical feature found on many proteins. It should be flagged as incorrect for use as an individual therapeutic target name.
Reducing agents restore or protect free thiol groups by breaking disulfide bonds
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein thiol group.